Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype - PubMed (original) (raw)
. 2003 Jul;84(Pt 7):1687-1699.
doi: 10.1099/vir.0.19074-0.
Affiliations
- PMID: 12810862
- DOI: 10.1099/vir.0.19074-0
Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype
Santanu Bose et al. J Gen Virol. 2003 Jul.
Abstract
Several host proteins have been shown to play key roles in the life-cycle of vesicular stomatitis virus (VSV). We have identified an additional host protein, cyclophilin A (CypA), a chaperone protein possessing peptidyl cis-trans prolyl-isomerase activity, as one of the cellular factors required for VSV replication. Inhibition of the enzymatic activity of cellular CypA by cyclosporin A (CsA) or SDZ-211-811 resulted in a drastic inhibition of gene expression by VSV New Jersey (VSV-NJ) serotype, while these drugs had a significantly reduced effect on the genome expression of VSV Indiana (VSV-IND) serotype. Overexpression of a catalytically inactive mutant of CypA resulted in the reduction of VSV-NJ replication, suggesting a requirement for functional CypA for VSV-NJ infection. It was also shown that CypA interacted with the nucleocapsid (N) protein of VSV-NJ and VSV-IND in infected cells and was incorporated into the released virions of both serotypes. VSV-NJ utilized CypA for post-entry intracellular primary transcription, since inhibition of CypA with CsA reduced primary transcription of VSV-NJ by 85-90 %, whereas reduction for VSV-IND was only 10 %. Thus, it seems that cellular CypA binds to the N protein of both serotypes of VSV. However, it performs an obligatory function on the N protein activity of VSV-NJ, while its requirement is significantly less critical for VSV-IND N protein function. The different requirements for CypA by two serologically different viruses belonging to the same family has highlighted the utilization of specific host factors during their evolutionary lineages.
Similar articles
- Determinants of serotype specificity in transcription of vesicular stomatitis virus synthetic nucleocapsids.
Smallwood S, Richards-Sumners E, Moyer SA. Smallwood S, et al. Virology. 1994 Feb 15;199(1):11-9. doi: 10.1006/viro.1994.1093. Virology. 1994. PMID: 8116233 - Differing responses of hamsters to infection by vesicular stomatitis virus Indiana and New Jersey serotypes.
Fultz PN, Holland JJ. Fultz PN, et al. Virus Res. 1985 Sep;3(2):129-40. doi: 10.1016/0168-1702(85)90003-6. Virus Res. 1985. PMID: 2414943 - Insights into the roles of cyclophilin A during influenza virus infection.
Liu X, Zhao Z, Liu W. Liu X, et al. Viruses. 2013 Jan 15;5(1):182-91. doi: 10.3390/v5010182. Viruses. 2013. PMID: 23322171 Free PMC article. Review. - Cyclophilin A: A Key Factor in Virus Replication and Potential Target for Anti-viral Therapy.
Dawar FU, Tu J, Khattak MN, Mei J, Lin L. Dawar FU, et al. Curr Issues Mol Biol. 2017;21:1-20. doi: 10.21775/cimb.021.001. Epub 2016 Mar 31. Curr Issues Mol Biol. 2017. PMID: 27033630 Review.
Cited by
- Cyclophilin A facilitates influenza B virus replication by stabilizing viral proteins.
Li H, Fan W, Min J, Bai X, Yang W, Li H, Zhao Y, Lin R, Jia X, Liu W, Sun L. Li H, et al. iScience. 2023 Nov 23;26(12):108515. doi: 10.1016/j.isci.2023.108515. eCollection 2023 Dec 15. iScience. 2023. PMID: 38089580 Free PMC article. - A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets.
Kratzel A, Kelly JN, V'kovski P, Portmann J, Brüggemann Y, Todt D, Ebert N, Shrestha N, Plattet P, Staab-Weijnitz CA, von Brunn A, Steinmann E, Dijkman R, Zimmer G, Pfaender S, Thiel V. Kratzel A, et al. PLoS Biol. 2021 Dec 28;19(12):e3001490. doi: 10.1371/journal.pbio.3001490. eCollection 2021 Dec. PLoS Biol. 2021. PMID: 34962926 Free PMC article. - Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?
Devaux CA, Melenotte C, Piercecchi-Marti MD, Delteil C, Raoult D. Devaux CA, et al. Front Med (Lausanne). 2021 Sep 6;8:663708. doi: 10.3389/fmed.2021.663708. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34552938 Free PMC article. Review. - Cyclophilin A: a possible host modulator in Chandipura virus infection.
Pavitrakar DV, Atre NM, Tripathy AS, Shil P. Pavitrakar DV, et al. Arch Virol. 2021 Nov;166(11):3143-3150. doi: 10.1007/s00705-021-05237-1. Epub 2021 Sep 17. Arch Virol. 2021. PMID: 34533641 Free PMC article. - Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products.
Zhang M, Zhong J, Xiong Y, Song X, Li C, He Z. Zhang M, et al. Viruses. 2021 Jun 28;13(7):1257. doi: 10.3390/v13071257. Viruses. 2021. PMID: 34203182 Free PMC article. Review.